| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-05-19 | Dec-31-18 | Dec-05-18 | Dec-31-17 |
| | 10-K | 10-K | 10-K | 10-K | 8-K | 10-K | 8-K | 10-K |
| Revenues: |
| Lyte | 15.3 | 3.1 | | | | | | |
| Phunware | 6.5 | 7.5 | | | | | | |
| Non-US | 0.7 | 0.7 | 0.3 | | | | | |
| Other | | | 9.7 | | | | | |
| Total revenues | 21.8 | 10.6 | 10.0 | 19.2 | 19.2 | 30.9 | 30.9 | 26.7 |
| Revenue growth [+] | 104.8% | 6.4% | -47.8% | -38.0% | -38.0% | 15.6% | | |
| Lyte | 393.5% | | | | | | | |
| Phunware | -13.6% | | | | | | | |
| Non-US | -6.7% | 123.5% | | | | | | |
| Cost of goods sold | 16.7 | 7.0 | 3.4 | 9.0 | 9.0 | 11.8 | 11.8 | 15.7 |
| Gross profit | 5.1 | 3.6 | 6.6 | 10.1 | 10.1 | 19.1 | 19.1 | 11.0 |
| Gross margin | 23.3% | 33.9% | 66.4% | 52.9% | 52.9% | 61.8% | 61.8% | 41.2% |
| Selling, general and administrative [+] | 26.4 | 16.3 | 17.0 | 18.1 | 18.1 | 19.0 | 19.0 | 25.5 |
| Sales and marketing | 6.8 | 3.0 | 1.7 | 2.7 | 2.7 | 5.4 | 5.4 | 10.7 |
| General and administrative | 19.6 | 13.3 | 15.4 | 15.4 | 15.4 | 13.6 | 13.6 | 14.8 |
| Research and development | 6.1 | 4.2 | 2.6 | 4.3 | 4.3 | 7.0 | 7.0 | 11.1 |
| Other operating expenses | 22.9 | 9.4 | 4.5 | | | 0.3 | | |
| EBITDA [+] | | | | -12.0 | -11.7 | -6.8 | | -24.2 |
| EBITDA growth | 92.0% | 49.9% | 46.0% | 77.2% | 70.7% | -72.0% | 696.0% | |
| EBITDA margin | -231.0% | -246.4% | -175.0% | -62.6% | -61.2% | -21.9% | -22.2% | -90.5% |
| Depreciation | -0.7 | -0.2 | -0.1 | 0.1 | 0.3 | 0.1 | | 0.2 |
| EBITA | -49.7 | -26.0 | -17.4 | -12.0 | -12.0 | -6.8 | -6.9 | -24.3 |
| EBITA margin | -227.9% | -244.2% | -173.5% | -62.9% | -62.9% | -22.1% | -22.2% | -91.1% |
| Amortization of intangibles | 0.7 | 0.2 | 0.1 | 0.3 | 0.3 | 0.4 | | 1.3 |
| EBIT [+] | -50.4 | -26.2 | -17.5 | -12.3 | -12.3 | -7.2 | -6.9 | -25.6 |
| EBIT growth | 92.0% | 49.9% | 42.1% | 71.1% | 79.4% | -71.9% | 696.0% | |
| EBIT margin | -231.0% | -246.4% | -175.0% | -64.3% | -64.3% | -23.3% | -22.2% | -95.9% |
| Non-recurring items [+] | -20.9 | -9.4 | | | | -0.3 | | |
| Asset impairment | -20.9 | -9.4 | | | | -0.3 | | |
| Interest expense | 2.4 | 4.5 | 3.4 | 0.6 | 0.6 | 0.7 | 0.7 | 0.4 |
| Interest expense | 2.4 | 4.5 | 3.4 | 0.6 | 0.6 | 0.7 | 0.7 | 0.4 |
| Other income (expense), net [+] | -19.0 | -32.6 | -1.3 | 0.0 | 0.0 | -2.6 | -2.6 | 0.0 |
| Litigation settlement | | | 4.5 | | | | | |
| Gain (loss) on debt retirement | | -8.0 | -2.2 | | | | | |
| Unrealized gain/loss on derivatives | 3.3 | -18.1 | 0.9 | | | | | |
| Change in fair value of warrants | 3.3 | -18.1 | 0.9 | | | -0.1 | | |
| Other | 0.6 | 0.0 | | 0.0 | 0.0 | -2.2 | 2.2 | 0.0 |
| Pre-tax income | -50.9 | -53.9 | -22.2 | -12.9 | -12.9 | -10.2 | -10.2 | -26.0 |
| Income taxes | 0.0 | -0.4 | 0.0 | 0.0 | 0.0 | -0.4 | -0.4 | -0.1 |
| Tax rate | | 0.8% | | | | 3.7% | 3.7% | 0.3% |
| Net income | -50.9 | -53.5 | -22.2 | -12.9 | -12.9 | -9.8 | -9.8 | -25.9 |
| Net margin | -233.5% | -502.9% | -222.0% | -67.2% | -67.2% | -31.7% | -31.7% | -97.1% |
| |
| Basic EPS [+] | ($0.51) | ($0.71) | ($0.50) | ($0.35) | ($0.35) | ($0.38) | ($0.38) | ($1.06) |
| Growth | -27.5% | 41.5% | 43.7% | -9.0% | -8.2% | -63.7% | 238.5% | |
| Diluted EPS [+] | ($0.51) | ($0.71) | ($0.50) | ($0.35) | ($0.35) | ($0.38) | ($0.38) | ($1.06) |
| Growth | -27.5% | 41.5% | 43.7% | -9.0% | -8.2% | -63.7% | 238.5% | |
| |
| Shares outstanding (basic) [+] | 99.0 | 75.4 | 44.3 | 36.9 | 36.9 | 25.6 | 25.8 | 24.5 |
| Growth | 31.2% | 70.4% | 20.0% | 44.3% | 43.0% | 4.2% | 842.4% | |
| Shares outstanding (diluted) [+] | 99.0 | 75.4 | 44.3 | 36.9 | 36.9 | 25.6 | 25.8 | 24.5 |
| Growth | 31.2% | 70.4% | 20.0% | 44.3% | 43.0% | 4.2% | 842.4% | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |